In this issue:
Microplastics and nanoplastics in atheromas
RNA interference agent zilebesiran for mild to moderate hypertension
Recurrence of AF in patients with new-onset AF after CABG
Cardiovascular outcomes in type 2 diabetics treated with various agents
Direct oral anticoagulants for stroke prevention in patients with device-detected AF
Angiotensin receptor + neprilysin inhibition in patients with STEMI vs NSTEMI
Remoteness does not affect post-MI outcomes in Victoria
Secondary prevention medications in metropolitan vs non-metropolitan areas of Victoria
Concomitant use of SSRIs and oral anticoagulants increases risk of major bleeding
Impact of empagliflozin on heart failure risk after MI
Please login below to download this issue (PDF)